<DOC>
	<DOCNO>NCT01142934</DOCNO>
	<brief_summary>TegaCHG multicentric randomize study aim evaluate possibility use TegaDerm CHG dressing may reduce incidence catheter relate blood stream infection ( CRBSI ) . It imply comparison incidence CRBSI patient central venous catheter dress TegaDerm without chlorhexidine gluconate ( CHG ) CHG . The primary endpoint occurrence CRBSI secondary endpoint : catheter colonization ( growth microbes culture catheter tip , &gt; 15 CFU accord semi-quantitative method &gt; 1000 CFU accord quantitative method ) ; incidence catheter exit site infection ; occurrence catheter relate infections/sepsis severe infection-related complication ; safety profile evaluation : occurrence hypersensitivity dress basis local objectivity ( erythema , edema , ) patient symptom ( itch , burn sensation ) ; relate device performance : incidence high/medium/low dress edge lift , ability visualize catheter insertion site , easiness removal , easiness dress application ; incidence unscheduled dress change . The study hypothesis implies use slow release device contain chlorhexidine may decrease incidence CRBSI . This already show chlorhexidine impregnate sponge . Scope study verify property also true TegaDerm CHG , new chlorhexidine-releasing dressing medication directly release integrate transparent gel pad , catheter exit site remain visible easy inspect without remove dressing .</brief_summary>
	<brief_title>Trial Efficacy Tegaderm Chlorhexidine Gluconate ( CHG ) Reducing Catheter Related Bloodstream Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>Age ≥ 18 year Hospitalized patient , either Intensive Care Unit nonIntensive Care ward setting Clinical indication insertion nontunneled central venous catheter ( exclude large bore catheter dialysis pheresis ) PICC Age &lt; 18 year Inability obtain informed consent Actual evidence recent history ( &lt; 30 day ) bloodstream infection Central line insert femoral vein Central line insert surgical cutdown Use call 'treated ' catheter , i.e . catheter whose internal and/or external surface coat antibacterial drug well catheter whose polyurethane release ion potential antiseptic action , exclude present protocol Specific intolerance know hypersensitivity transparent dressing chlorhexidine Any form dermatitis , burn , skin lesion tattoo insertion site Burns ≥ 15 % body surface area Use topical antibiotic within 10cm catheter insertion site Enrollment another investigational drug device study time study 30 day prior .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Catheter-related bloodstream infection</keyword>
	<keyword>Chlorhexidine</keyword>
	<keyword>Transparent dressing</keyword>
</DOC>